Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Massachusetts, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Biotechnology
  • Health Tech
  • AI
About
Ginkgo Bioworks utilizes advanced biological technology to develop a cell programming platform that enhances the production of biotechnology products across various sectors, including food, fragrance, and pharmaceuticals.
Min check size
$100K
Max check size
$50M
Fund size
NPS

Investment Thesis

They Invest in biotechnology across diverse markets, using advanced biological engineering to create transformative solutions in food, fragrance, pharmaceuticals, and more.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Backed by extensive experience in venture capital, the fund manager has successfully executed over 25 deals, primarily focusing on biotechnology and sustainable agriculture sectors. Active across North America and Europe, the strategic approach emphasizes operator-first investments, ensuring strong partnerships with founders. Notable exits include several high-profile biotech firms that have substantially impacted their respective markets. Committed to early-stage investments, the manager employs a data-driven methodology to identify and nurture innovative opportunities.

Ginkgo Bioworks Contacts Information

Primary contact

Secondary contact

Team

Zsofia Magarian

Zach Smith

Will Schroeder

Thomas Knight

Sushmita Venkatraman

Sneha Srikrishnan

Sean Leblanc

Samantha Sutton

Russell Heissner

Reshma Shetty

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp